Hemant Surgical Industries Ltd
BSE:543916
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
21.48
1 070.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Hemant Surgical Industries Ltd
Revenue
Hemant Surgical Industries Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hemant Surgical Industries Ltd
BSE:543916
|
Revenue
₹1.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
K
|
Kretto Syscon Ltd
BSE:531328
|
Revenue
₹127m
|
CAGR 3-Years
54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
44%
|
|
|
T
|
Trimurthi Ltd
BSE:536565
|
Revenue
₹28.7m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
D
|
Dipna Pharmachem Ltd
BSE:543594
|
Revenue
₹1.2B
|
CAGR 3-Years
20%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
A
|
Achyut Healthcare Ltd
BSE:543499
|
Revenue
₹30.5m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hemant Surgical Industries Ltd
Glance View
Hemant Surgical Industries Ltd. operates as a pharmaceutical company. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2023-06-05. The firm's product offerings cover a spectrum of equipment and disposables required for renal care, cardiovascular disease, respiratory disease, critical care and radiology and surgical disposables. Its range of products includes the indigenously manufactured products along with some other products that are imported from countries, such as Japan, China and France, Australia and are further processed in our assembly units. Its product categories include Aero Healthcare Products, JMS Products, Dialysis Products and Covid Care Products. Its services include home dialysis treatment, home dialysis solution on outright purchase, turnkey dialysis center setup, dialysis center management, dialysis machine on a rental basis, AMC/CMC contract for the dialysis machine and oxygen concentrator on a rental basis.
See Also
What is Hemant Surgical Industries Ltd's Revenue?
Revenue
1.1B
INR
Based on the financial report for Mar 31, 2025, Hemant Surgical Industries Ltd's Revenue amounts to 1.1B INR.
What is Hemant Surgical Industries Ltd's Revenue growth rate?
Revenue CAGR 5Y
14%
Over the last year, the Revenue growth was 1%. The average annual Revenue growth rates for Hemant Surgical Industries Ltd have been 1% over the past three years , 14% over the past five years .